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neurons through STAT3
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,1,3
Afteraxotomyofembryonichippocampalneuronsinvitro,someoftheaxotomizedaxonslosetheiridentity,andnewaxonsarise
and grow. This axotomy-induced axonogenesis requires importin, suggesting that some injury-induced signals are transported
via axons to elicit axonogenesis after axotomy. In this study, we show that STAT3 is activated in response to axotomy. Because
STAT3 was co-immunoprecipitated with importin b in the axotomized neurons, we suggest that STAT3 is retrogradely
transported as molecular cargo of importin a/b heterodimers. Indeed, inhibition of importin a binding with STAT3 resulted in the
attenuation of axonogenesis. Silencing STAT3 blocked the axonogenesis, demonstrating that STAT3 is necessary for axotomy-
induced axonogenesis. Furthermore, the overexpression of STAT3 enhanced axotomy-induced axonogenesis. Taken together,
these results demonstrate that activation and retrograde transport of STAT3 in injured axons have key roles in the axotomy-
induced axonogenesis of hippocampal neurons.
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The cell body of an injured neuron must receive accurate and
timely information about axonal damage to reproduce
polarization. It has been widely recognized that a dendrite is
transformed into a new axon and that an injured axon regrows
after axonal injury.
1,2 In addition to examining these
responses, we have focused on the previously unrecognized
phenomenon of a new neurite arising from a cell body after
axotomy and becoming an axon.
3 In approximately one-tenth
of cultured rat hippocampal neurons on embryonic day (E)
18–19, new neurites arise from cell bodies and grow after
axotomy (axonogenesis).
3 These neurites become Tau-1
positive, and the injured axons lose immunoreactivity for Tau-1.
This axotomy-induced axonogenesis is the third form of
response to axonal injury and may be important for plasticity
induced by axonal injury. The mechanism underlying this
phenomenon has remained a signiﬁcant question, however.
Because the cell bodies of injured neurons must receive the
signals for axonal damage to produce new axons, we
reasoned that an injury signal would be transported retro-
gradely to the cell body by the dynein–dynactin complex.
Indeed, axonogenesis can be delayed in these neurons by
inhibiting the dynein–dynactin complex through overexpres-
sion of p50.
3 Importin b, which is locally translated after
axotomy, associates with dynein and is required for axotomy-
induced axonogenesis in hippocampal neurons.
3 Importin a
protein is constitutively complexed with the retrograde motor
dynein; after lesioning, importin b1 mRNA localizes in the
axoplasm and is rapidly translated into importin b1 protein,
leading to the formation of importin a/b1 heterodimers bound
to the retrograde motor dynein.
4 Thus, the axoplasmic
importin–dynein complex enables retrograde injury signaling
in injured axons. The identiﬁcation of the molecules that are
retrogradely transported is expected to elucidate the mechan-
ism of this interesting phenomenon.
Other studies have identiﬁed a number of transcriptional
factors in peripheral nerve axons that might be implicated in
retrograde signaling,
5 some of which have been reported to
interact with importins and their associated molecules for
nucleocytoplasmic transport. It is tempting, therefore, to
speculate that transcriptional factors interact in axons via
importin–dynein-mediated transport as well. Our study
showed that STAT3 was activated in response to axotomy
and was required for axotomy-induced axonogenesis.
Results
STAT3 inhibitor attenuates axotomy-induced
axonogenesis. We cultured hippocampal rat neurons
(E18–19) at low density for 3 days and cut the axons of the
stage 3 polarized neurons. We then observed morphological
changes in these neurons for 12h using time-lapse imaging.
Among 65 axotomized neurons (excluding 10 neurons that
died within 3h of axotomy), axotomized axons regrew in
35 neurons. The remaining dendrites became new axons in
7 neurons, and new neurites arose from the cell bodies after
axotomy, grew, and became Tau-1 positive (axonogenesis)
in 8 neurons.
3 This axonogenesis was speciﬁc to the
axotomized neurons, because it was never observed in 62
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3 We assumed
that some injury-induced signals would be transported with
importin a/b heterodimers and dynein complex from the injury
site to the cell body. Therefore, we sought to determine the
signal that is transported in the axotomized neurons.
STAT3,
6–12 NF-kB,
13–15 nuclear factor of activated T cells
(NFAT),
13,16–18 and ERK
19,20 are known molecular cargoes
of importin, and they also have roles in axon outgrowth and
neuronal survival.
We treated axotomized neurons with membrane-perme-
able inhibitors AG490 (a STAT3 inhibitor), 6-amino-4-
(4-phenoxyphenylethylamino) quinazoline (an inhibitor of
NF-kB), U0126 (an inhibitor of ERK), and 11R-vivit (a NFAT
inhibitor). AG490efﬁcientlyinhibited axonogenesisbut didnot
modulate the regrowth response (Figure 1a). Although the
NF-kB and ERK inhibitors prevented axonogenesis, they also
blockedtheregrowthresponse(Figures1bandc),suggesting
that these agents suppress the outgrowth of processes
nonspeciﬁcally. The NFAT inhibitor did not modulate axot-
omy-induced axonogenesis (Figure 1d). These results
prompted us to focus on the role of STAT3 in axotomy-
induced axonogenesis.
STAT3 is activated after axotomy. We tested whether
STAT3 was activated after axotomy. The axons of the
polarized neurons at 3 days in vitro (DIV) were cut and
immunostained for phosphorylated STAT3 (pSTAT3) at
10min, 1, and 3h after axotomy. The level of pSTAT3 in
the nucleus of the axotomized neurons increased
signiﬁcantly at 1h after axotomy compared with that of
non-axotomized neurons (Figures 2a–c). When p50 was
transfected with the neurons, however, upregulation of
axotomy-induced pSTAT3 in the cell bodies disappeared
(Figure 2c).
Next, we evaluated the amount of pSTAT3 in the
axotomized neurons. To obtain enough protein for Western
blotting, we used an explant culture of the hippocampus from
E18rats. Wecut theaxons ofthe hippocampalexplants with a
blade (Figure 2d) and collected the cell bodies, including the
proximalaxonsandthedistalaxons(Figure2e)at0,5,10min,
and 1h after axotomy. The phosphorylation level of STAT3
was increased after axotomy in both the cell bodies and distal
axons (Figures 2e–g). The phosphorylation levels of STAT3
increased gradually up to 10min after axotomy and remained
highevenat1hafteraxotomyinthecellbodiesandinjuredthe
proximalaxons(Figures2eandf).Inthedistalaxons,thelevel
of pSTAT3 peaked 10min after axotomy and decreased
below the baseline 1h after axotomy (Figures 2e and g).
These results demonstrate that pSTAT3 increased in the
axons in response to axotomy.
STAT3 is transported through injured axons with
importin b. We examined the interaction between pSTAT3
and importin b in axotomized hippocampal neurons.
Coimmunoprecipitation analysis revealed that pSTAT3 was
associated with importin b1, and this association was
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Figure 1 Inhibitor study on axotomy-induced axonogenesis Effects of signal transduction inhibitors on the responses of axotomized hippocampal neurons at 3 DIV. The
graphsshowthenumberofneuronswiththeindicatedmorphologicalchanges.Afteraxotomy,axonogenesis,butnotregrowthoftheinjuredaxons,wassuppressedbyAG490
(a; n¼74).Regrowth as well as axonogenesiswas inhibited by treatment with NFkB inhibitor (b; n¼35) or U0126 (c; n¼13). No signiﬁcant effect was observed with NFAT
inhibitor (d; n¼10)
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Cell Death and Diseaseincreased at 1h after axotomy (Figure 3a). We have reported
that importin b increases in axons in response to axotomy
and that they interact with the dynein motor complex for
retrograde transport.
3 These results suggest that pSTAT3
interacts with dynein–importin a/b heterodimers for
retrograde transport.
We then attempted to assess whether the binding of
STAT3 with importin a/b heterodimers was required for
axotomy-induced axonogenesis. Because Arg214/215 of
STAT3 is the binding site for importin a5,
7,21 we intended to
block the binding of STAT3 with importin a5 speciﬁcally by
usingSTAT3,a10-amino-acidresiduepeptide(210–219)that
includes the binding site of STAT3 with importin a5. This
peptide was fused with the amino (N)-terminal protein
transduction domain (11 amino acids) from the HIV protein
TAT-protein transduction domain (TAT-PTD) and conjugated
with ﬂuorescein (FLC) to produce FLC-TAT-PTD-STAT3
(210–219). We used immunocytochemistry to conﬁrm that
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Figure 2 STAT3 is required for axotomy-induced axonogenesis (a) Immunocytochemistry for phosphorylated STAT3 (pSTAT3) before and at 1h after axotomy. pSTAT3
was increased in the nuclei of axotomized hippocampal neurons (arrowhead) compared with the non-axotomized neurons (asterisks). Arrows indicate the injury site, and
arrowheads indicate the cell bodies of axotomized neurons. Scale bar, 50mm. (b) The hippocampal neurons were double-immunostained for pSTAT3 (red) and DAPI (blue).
pSTAT3 was expressed in the nucleus of the neurons after axotomy. Scale bar, 20mm. (c) Relative level of pSTAT3 in the nucleus. The level of pSTAT3 in the nucleus of
axotomized neuronsincreasedsigniﬁcantly at1h afteraxotomybutreturnedto thecontrollevel3h afteraxotomy.In cellswith p50overexpression, thelevel of pSTAT3inthe
nucleus did not increase at 1 or 3h after axotomy (each group, n¼13–15). The ratio of pSTAT3/STAT3 was calculated from the ﬂuorescent intensities in
immunocytochemistry.Dataare representedasmean±S.E.M.*Po0.05.(d)Procedurefortransfectionofneuritesfromtheexplant.(e)Westernblotanalysisoflysatesfrom
axotomizedhippocampalexplantsfrom0minto1hafteraxotomy.Lysateswereobtainedfromthecellbodiesthatincludedtheproximalaxonsaswellasfromthedistalaxons.
(fandg)RelativechangesinthelevelofpSTAT3.ThelevelofpSTAT3increasedat5and10minafteraxotomyinbothtissues.Theratiowasobtainedbymeasuringtheband
intensities. In the cell bodies and proximal axons (f), the increase was gradual and remained high 60min after axotomy. In the distal axons (g), the increase peaked at 10min
after axotomy and decreased dramatically thereafter. Data are represented as the mean±S.E.M. of three independent experiments. **Po0.01; *Po0.05 compared
with control
Axonal injury induces axonogenesis through STAT3
R Ohara et al
3
Cell Death and DiseaseFLC-TAT-STAT3(210-219)
FLC-TAT-STAT3(210-219) p-STAT3 p-STAT3
DAPI
importin α5
DAPI
N
u
m
b
e
r
TAT-PTD control
TAT-PTD STAT3(210-219)
0
2
4
6
8
10
12
14
16
N
u
m
b
e
r
0
5
10
15
20
25
30
TAT-PTD
control  
TAT-PTD
STAT3 -219210
**
axonogenesis (-)
axonogenesis (+)
IB: p-STAT3
IP imp-β
axotomized
imp-β
Lysates
IB: p-STAT3
imp-β
0 h 1 h
Figure 3 STAT3 binding to importin is required for axotomy-induced axonogenesis (a) Coimmunoprecipitation of importin b1 with pSTAT3. Lysates were prepared from
hippocampal explants at 1h after axotomy. (b) Immunostaining of a hippocampal neuron at 3 DIV reveals expression of importin a5. Scale bar, 50mm. (c) Fluorescein-TAT-
protein transduction domain-STAT3 (FLC-TAT-PTD-STAT3) (210–219) was efﬁciently transduced in the hippocampal neurons. Scale bar, 50mm. (d) The hippocampal
neuronswere double-immunostainedfor pSTAT3(red) andDAPI (blue).pSTAT3was expressedinthecytoplasm,butnotin thenucleusin theneuronstransducedwith FLC-
TAT-PTD-STAT3 (210–219). Scale bar, 30mm. (e) Number of neurons with the indicated morphological changes. No axonogenesis occurred after axotomy in the neurons
transduced with FLC-TAT-PTD-STAT3 (210–219) (n¼28). TAT-PTD control neurons, n¼16. (f) Number of neurons with and without axonogenesis. Axonogenesis was
attenuated in neurons transduced with TAT-PTD STAT3 (210–219), but not in those transduced with TAT-PTD control. **Po0.05
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Cell Death and Diseaseimportin a5 was expressed in rat hippocampal neurons
(Figure 3b). In the dissociated culture of the hippocampal
neurons, we transduced FLC-TAT-PTD-STAT3 (210–219)
(Figure 3c). Immunocytochemical data revealed that the
signal for pSTAT3 was absent in the nuclei of neurons
transduced with FLC-TAT-PTD-STAT3 (210–219), demon-
strating that the binding of STAT3 with importin a5 was
blocked successfully by transduction of FLC-TAT-PTD-
STAT3 (210–219) (Figure 3d). By transducing this peptide,
we attenuated injury-induced axonogenesis completely
(Figures 3e and f). Thus, the binding of STAT3 with importin
a5 is required for axotomy-induced axonogenesis.
STAT3 is required for the axotomy-induced
axonogenesis. We next investigated the role of STAT3 in
axotomy-induced axonogenesis by knocking down its
endogenous expression in cultured hippocampal neurons.
Nucleofection with the STAT3 siRNA construct, but not with
the control siRNA construct, decreased STAT3 expression in
the hippocampal neurons at 3 DIV (Figure 4a). We performed
nucleofection of the STAT3 siRNA construct in combination
with the GFP construct to visualize the transfected neurons
(Figure 4b). We transected the axons of the transfected
neurons and found that neurons transfected with STAT3
siRNA did not have a signiﬁcantly different number of
processes (Figure 4c) or axonal length (Figure 4d)
compared with those transfected with control siRNA. Thus,
STAT3 is not involved in the neuritogenesis or the elongation
of the processes of uninjured neurons. We observed no
axonogenesis after axotomy in the 38 STAT3 siRNA-
transfected neurons, however (Figures 4e and f). Thus,
STAT3 appears to be necessary for axotomy-induced
axonogenesis.
Overexpression of STAT3 promotes axotomy-induced
axonogenesis. We transfected Flag-tagged STAT3
construct in combination with GFP into the cultured
hippocampal neurons. We veriﬁed that almost all of the
STAT3
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Figure 4 STAT3 is required for axotomy-induced axonogenesis. (a) Western blot analysis for the detection of STAT3. The hippocampal neurons at 3DIV were
cotransfected with STAT3 siRNA or control siRNA in combination with GFP. (b) Immunostaining for STAT3 shows that the expression of STAT3 decreased in the STAT3
siRNA-transfectedneuronscomparedtonon-transfectedneighboringneurons.Scalebar,50mm.(c)Numberofneurites.Culturedhippocampalneuronsweretransfectedwith
STAT3siRNA (n¼23) or control siRNA(n¼20).Data are representedas mean±S.E.M.(d) Axonal length. Dataare representedas mean±S.E.M. (e)Number of neurons
withtheindicatedmorphologicalchanges.NoaxonogenesisoccurredafteraxotomyintheneuronstransfectedwithSTAT3siRNA(n¼38).ControlsiRNA,n¼17.(f)Number
of neurons with and without axonogenesis. Knockdown of STAT3 inhibited axonogenesis. **Po0.01
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Cell Death and DiseaseGFP-expressing neurons also expressed Flag-tagged
STAT3 (Figure 5a). Neurons overexpressing STAT3
showed no signiﬁcant difference in the number of
processes (Figure 5b) or in axonal length (Figure 5c)
compared with those of neurons expressing GFP alone.
Interestingly, axonogenesis after axotomy occurred in 12 out
of 28 STAT3-overexpressed neurons, whereas the same
occurred in 9 out of 52 neurons expressing GFP alone
(Figures 5d and e), which indicates that axotomy-induced
axonogenesis is enhanced by the overexpression of STAT3.
These results demonstrate that STAT3 accelerates axotomy-
induced axonogenesis.
Discussion
In this study, we have shown that STAT3 is involved in
axonogenesis after axotomy. STAT3 is activated in response
to axotomy and is transported with importin b through the
injured axons. STAT3 is required speciﬁcally for the axotomy-
induced axonogenesis, and overexpression of STAT3
promotes this event.
Accumulated evidence suggests that STAT3 participates in
the responses of injured neurons in vitro and in vivo. It has
been reported previously that axotomy increases pSTAT3 in
thesciaticnerve.
9,22,23Moreover,pSTAT3hasbeenshownto
be transported retrogradely from an injury site to the cell body
after sciatic nerve, facial nerve, and hypoglossal nerve
lesioning.
24 STAT3 is activated in injured sensory neurons,
and the application of a JAK inhibitor attenuates the injury
response in vitro.
25 Further, in vivo peripheral nerve lesioning
has been demonstrated to lead to a very rapid activation of
STAT3 in sciatic nerve axons at the lesion site.
22 This
response increases during the ﬁrst 24h after injury and
extends back to cell bodies over a time course consistent with
that required for the retrograde transport of activated STAT3
from injury site to cell body.
22 The phosphorylation of STAT3
and its translocation from cytoplasm to the nuclei of DRG
neurons and motor neurons are increased after injury,
9,24 and
STAT3 has been reported to interact with a number of
importins.
6,8 Taken together, these ﬁndings suggest that
STAT3 is retrogradely transported to elicit responses to
axonal lesioning. Although STAT3 regulates a wide variety of
responses in neurons, the present study is the ﬁrst to
demonstrate that it is involved in axonogenesis. Intriguingly,
the data suggest that STAT3 is not a global regulator of
axonogenesis but is speciﬁcally associated with injury-
induced axonogenesis.
Axonogenesisafteraxotomywasspeciﬁcallysuppressedin
neurons transfected with STAT3 siRNA, as the siRNA
transfection had no effect on the number of processes or
the axonal elongation of uninjured cells. STAT3 is activated in
response to growth factors, cytokines, and hormones known
to have a protective role after cerebral ischemia and nerve
injury.
26–28 Schweizer et al
12 used a tissue-speciﬁc gene
ablation of STAT3 in motor neurons to study the role of neural
STAT3 in nerve injury in adults and reported that STAT3
contributes to motor neuron protection after injury-induced
neuronal death. Naturally occurring motor neuron death
during the embryonic period was not enhanced in neuroﬁla-
ment light chain promoter–Cre STAT3-knockout mice.
Facial motor neuron survival was signiﬁcantly reduced in
thesemiceafternervelesioninginadults,however.Thisresult
suggests that STAT3 has an important role in promoting
neuronalsurvivalafterinjury.Consistentwiththisobservation,
knockdown of STAT3 increased neuronal death after
axotomy in our study. Because more than half of the STAT3
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Cell Death and DiseasesiRNA-transfected neurons died within 6h after axotomy,
STAT3 appears to be necessary for cells to survive axotomy.
Hence, STAT3 contributes to survival and axonogenesis in
axotomized neurons.
The neuropoietic cytokines IL-6, leukemia inhibitory factor
(LIF),andciliaryneurotrophicfactor(CNTF), whichareknown
to be induced after ischemia and nerve injury and which exert
neuroprotective and regenerative effects,
27,29–33 share the
signaling receptor gp130. In peripheral nerves, CNTF is
storedinthecytoplasmofSchwanncellsandmaybereleased
byinjury.
34–38LIF andIL-6 are presentatvery low levelsin the
nerve as well.
39–42 After experimental axonal injury, IL-6 was
synthesizedin cortical, thalamic, and hippocampal neurons.
43
Although STAT3 was phosphorylated in axotomized neurons,
it remains unknown which ligand phosphorylated STAT3 after
axonal injury. Because we used dissociated cultures of
hippocampal neurons in this study, we assumed that the
injured neurons themselves produced some ligand, such as
IL-6, CNTF, or LIF, that activated STAT3 or that they induced
STAT3 activation independent of any ligand.
The in vivo relevance of our observations is an issue to be
addressed in the future. In vivo synaptic plasticity in the
formationofnewcircuitsthroughcollateralsproutingofinjured
axons is an important component of the functional recovery
process in patients with central nervous system injury.
44,45
These reorganization processes possibly occur in cortical and
subcortical motor areas. Whether axonogenesis occurs and
hasaroleinrecoveryaftercentralnervoussysteminjury,such
as traumatic brain injury and spinal cord injury is unknown,
however. The next challenge will be to explore whether new
axons arise in vivo from cell bodies of neurons after these
injuries.
Materials and Methods
Dissociated cell culture. All experimental procedures were approved by the
Institutional Ethics Committee of Osaka University. Hippocampal neurons obtained
from Wistar rat pups on E18–19 were dissociated using trypsinization (treatment
with 0.25% trypsinin PBS for 15min at 371C) andthen resuspendedin DMEM/F12
(Invitrogen, Carlsbad, CA, USA) containing 10% FBS and triturated. Subsequently,
the neurons were washed three times. The cells were suspended in DMEM/F12
containing 10% FBS, plated on poly-L-lysine- and laminin-coated dishes, and
maintained at 371Ci n5 %C O 2. The culture medium was replaced with serum-free
DMEM/F12 supplemented with B27 (Invitrogen) at 12h after plating, by when the
cells had attached. For the immunocytochemistry experiments to detect pSTAT3,
cells were suspended in DMEM/F12 containing 3% FBS, and the culture medium
was replaced with serum-free DMEM/F12 supplemented with B27 at 12h after
platingbecausethelevelofpSTAT3inhippocampalneuronsisincreasedbyserum.
Where indicated, the following reagents were used at the indicated concentrations:
50mM AG490 (a STAT3 inhibitor; Calbiochem, San Diego, CA, USA), 50nM
6-amino-4-(4-phenoxyphenylethylamino) quinazoline (an inhibitor of nuclear factor-
kB [NF-kB]; Calbiochem), 10mM U0126 (an inhibitor of ERK; Calbiochem), 1mM
11R-vivit (RRRRRRRRRRR-GGG-MAGPHPVIVITGPHEE, an inhibitor of NFAT;
Calbiochem). Cells were pretreated with each inhibitor for 30min before axotomy.
Explant culture. The hippocampus was removed from Wistar rat pups on E18
according to a previously reported method, with slight modiﬁcation.
46 The
hippocampus was chopped into 300- to 600-mm pieces using ﬁne tweezers.
These pieces were placed in a 3.5-cm tissue culture dish containing DMEM/F12,
1.5ml and supplemented with 10% FBS. After 2 days of incubation at 371Ci na
5% CO2 incubator, the medium was replaced with DMEM/F12 supplemented with
2% B27. At 10 DIV, the extended neurites were transected with a blade, according
to a previously reported method.
47
Nucleofection procedure. For each transfection experiment, 4.0–5.0 10
6
cells were used with the Nucleofector II device (Amaxa Biosystems, Ko ¨ln,
Germany).Dissociatedhippocampalneuronswerespunat800r.p.m.for3min,and
the medium was removed. Cells were then resuspended in 100ml of rat neuron
Nucleofectorsolution(AmaxaBiosystems)atRT,and5mgofplasmidswereadded,
including GFP-expression vector (Amaxa Biosystems) and Flag-STAT3-C Flag
pRc/CMV (Addgene, Cambridge, MA, USA) at the ratio of 1:10. The mixture of
neurons, solution, and plasmids was transferred to a 2-mm electroporation cuvette
(Amaxa Biosystems), inserted into the Nucleofector, and processed with program
O-03. Immediately after transfection, 1mL of DMEM/F12 supplemented with 10%
FBS was added to the hippocampal neurons to reduce damage, and the cells were
plated on poly-L-lysine- and laminin-coated dishes. The culture medium was
replaced with serum-free DMEM/F12, supplemented with B27 at 3h after plating to
reduce damage to the cells. To knockdown the expression of STAT3, the neurons
were cotransfected with 500pmol of rat STAT3 siRNA (50-CCACUCUGGUGUUU
CAUAACCUCUU-30) (Stealth Select RNAi; Invitrogen) or control siRNA (Stealth
RNAi Negative Control Low GC Duplex; Invitrogen) in combination with 2.5mgo f
GFP-plasmid (Amaxa Biosystems). The number of processes and axonal length of
the neurons were measured at 48h after nucleofection.
Axotomy and time-lapse imaging. The culture dish was secured in a
chamber that was supplied continuously with 5% CO2 in air. The chamber was
placed on an Olympus IX81 inverted phase-contrast microscope equipped with a
heated stage apparatus (model MI-IBC-IF; Olympus, Tokyo, Japan). We chose
10–15polarizedhippocampalneuronsineachdishat3DIVandcuttheaxonsofthe
neurons using a 30-G needle through the microscope. Images of the axotomized
neurons were acquired every 3min for 12h using a  40 objective lens with a
charge-coupled device video camera (Cooke, Kelheim, Germany). Images were
combined into a time-lapse sequence using the MetaMorph software (Molecular
Devices, Sunnyvale, CA, USA).
Transduction of TAT–PTD fusion protein. FLC—TAT–PTD
(YGRKKRRQRRR)-STAT3 210–219 (LDQMRRSIVS) fusion peptide and
FLC–TAT–PTD (YGRKKRRQRRR)–(SRQLVMRDIS) fusion peptide (control)
were synthesized by Sigma Genosys (Ishikari, Japan). The peptides, which were
puriﬁed using preparative reverse-phase HPLC, displayed 495% purity.
Hippocampal neurons were incubated with 5mmol FLC–TAT–PTD-STAT3
210–219 or FLC–TAT–PTD in serum-free DMEM/F12 supplemented with B27 for
3h at 3 DIV. Subsequently, the neurons were washed with PBS, and the culture
medium was replaced with serum-free DMEM/F12 supplemented with B27. The
treated neurons were observed for 12h after axotomy using time-lapse imaging.
Fluorescence immunostaining. Cells were ﬁxed in 2% paraformaldehyde
and 2% sucrose in 0.1mol phosphate buffer for 20min at RT. They were incubated
with a blocking solution containing 5% BSA and 0.1% Triton-X in PBS for 1h and
overnight at 41C with anti-importin a5 (diluted 1:100 in the blocking solution;
Sigma-Aldrich,St. Louis, MO, USA), anti-phosphoSTAT3 (Ty705) antibody(diluted
1:500intheblockingsolution;CellSignalingTechnology,Danvers,MA,USA),anti-
STAT3(124H6)mousemonoclonalantibody(diluted1:500intheblockingsolution;
Cell SignalingTechnology),andanti-FLAGantibody(diluted1:1000intheblocking
solution; Sigma-Aldrich). After primary antibody incubation, sections were washed
three times with PBS and incubated with 1mg/ml DAPI and ﬂuorescent dye Alexa
488-conjugated anti-rabbit IgG or 568-conjugated anti-mouse IgG (diluted 1:1000
in 5% BSA in PBS; Molecular Probes/Invitrogen) at RT for 1h. They were then
observed with an Olympus IX81 inverted phase-contrast microscope.
Western blotting. Cells were lysed using a mixture containing 50mmol
Tris-HCl (pH 7.4), 150mM NaCl, 1% Np-40, 0.1% SDS, 2mmol EDTA, 1mmol
Na3VO4, 1mmol NaF, and a protease inhibitor (Roche Diagnostics, Indianapolis,
IN, USA). The homogenate was centrifuged at 15000r.p.m. for 10min, and the
supernatant was stored at  201C. The protein concentration was measured using
abicinchoninicacidproteinassaykit(Pierce;ThermoFisherScientiﬁc,Rockford,IL,
USA). An equal amount of the protein was loaded into each lane, run on
SDS-PAGE, and transferred to a PVDF membrane (Millipore, Billerica, MA, USA).
Theprotein sampleswere boiledin samplebuffer for5min,run on SDS-PAGE,and
transferred to PVDF membranes (Millipore). The membranes were blocked for 1h
at RT with 5% BSA and incubated for 2h at RT with anti-phospho STAT3(Ty705)
antibody (diluted 1:1000; Cell Signaling Technology) or anti-STAT3(124H6)
antibody (diluted 1:500; Cell Signaling Technology). HRP-conjugated secondary
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(GEHealthcare,London,UK)wereusedfordetection.Themembranewasexposed
to X-ray ﬁlm or the LAS-3000 image system (Fujiﬁlm, Tokyo, Japan), according to
the manufacturer’s speciﬁcations.
Coimmunoprecipitation assay. Rat hippocampal explants were lysed in
50mol Tris-HCl (pH 7.5), 150mmol NaCl, 10% glycerol, and 1% NP-40
supplemented with protease inhibitor cocktail tablets (Roche Diagnostics). The
lysates were incubated on a rocking platform at 41C for 20min and clariﬁed by
centrifugation at 13000 g at 41C for 10min. The supernatants were precleared
for 30min by incubating with 60ml of protein-G Sepharose beads (GE Healthcare).
After a brief centrifugation to remove the precleared beads, the cell lysates were
incubated overnight (for coimmunoprecipitation with rat hippocampal explants
extracts) at 41C with anti-importin b antibody (Abcam, Cambridge, MA, USA). The
immunocomplexes were collected for 1h at 41C with protein-G Sepharose beads
coated with 0.1% BSA in PBS. The beads were washed four times with lysis buffer.
The bound proteins were solubilized with  2 sample buffer and subjected to SDS-
PAGE followed by immunoblotting.
Morphometric analysis. We classiﬁed the morphological changes of
axotomized neurons into ﬁve groups as follows: axonogenesis, new neurites that
arose from cell bodies after axotomy and grew; dendrites that changed into axons,
dendrites that grew and became axons instead of axotomized axons; regrowth,
axotomized axons that regrew; no change, axotomized axons that retracted or
showed no morphological change; and death, neurons died within 3h of axotomy.
We performed immunocytochemistry for Tau-1 in the ﬁrst set of experiments, and
conﬁrmed that all the new neurites that arose from cell bodies after axotomy and
grew were axons.
3
Forthequantiﬁcationofneuriteoutgrowth,imageswerecapturedonanOlympus
IX81 inverted phase-contrast microscope mounted with a charge-coupled device
video camera (Cooke, Leicester, UK) using a  20 objective lens. Analysis was
performed using MetaMorph software (Molecular Devices). Twenty to twenty-eight
neurons per well were analyzed. Processes were deﬁned as neurites that emerged
from the cell body, and an axonal length was deﬁned as the length of the longest
neurite.
Statistical analysis. Signiﬁcant differences in the data for axonogenesis after
axotomy (Figures 3f, 4f and 5e) were determined using the w
2-test. Signiﬁcant
differences in other data were determined using Scheffe’s multiple comparison
tests. A P-valueo0.05 was considered signiﬁcant.
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